Search Results 181-190 of 16471 for Proto-oncogene
This clinical trial studies the effect of short-term (acute) and long-term (chronic) exercise on immune characteristics and function (phenotype) of patients ...
Rochester, Minn. The purpose of this study is to: Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz ...
Rochester, Minn. The purpose of this study is to evaluate how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the ...
Whaley RD, Sill DR, Tekin B, McCarthy MR, Cheville JC, Ebare K, Stanton ML, Reynolds JP, Raghunathan A, Herrera Hernandez LP, Jimenez RE, Sharma V, ...
Learn about the latest tools, such as T-cell therapy and cancer vaccines, that use the body's immune system to fight cancer.
Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...
This care coordinates genetic testing for diagnosis with any further cancer screening needed for prevention or early detection of colorectal cancer. Mayo Clinic ...
A high-resolution CRISPR tiling screen of RUVBL1 identified lysine 108 (K108) as a critical residue for binding the oncogenic MYC protein and promoting Ewing ...
Adenocarcinoma is a type of cancer that starts in gland cells. Learn about symptoms, diagnosis, grades, stages, treatment and prognosis.
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.